M K Strother1, M D Anderson2, R J Singer3, L Du4, R D Moore2, Y Shyr4, T R Ladner2, D Arteaga2, M A Day2, P F Clemmons2, M J Donahue5. 1. From the Departments of Radiology and Radiological Sciences (M.K.S., M.D.A., R.D.M., T.R.L., D.A., M.A.D., P.F.C., M.J.D.) Megan.strother@vanderbilt.edu. 2. From the Departments of Radiology and Radiological Sciences (M.K.S., M.D.A., R.D.M., T.R.L., D.A., M.A.D., P.F.C., M.J.D.). 3. Section of Neurosurgery (R.J.S.), Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. 4. Vanderbilt Center for Quantitative Sciences (L.D., Y.S.); Vanderbilt University School of Medicine, Nashville, Tennessee. 5. From the Departments of Radiology and Radiological Sciences (M.K.S., M.D.A., R.D.M., T.R.L., D.A., M.A.D., P.F.C., M.J.D.)Neurology (M.J.D.)Psychiatry (M.J.D)Physics and Astronomy (M.J.D.).
Abstract
BACKGROUND AND PURPOSE: Cerebrovascular collaterals have been increasingly recognized as predictive of clinical outcomes in Moyamoya disease in Asia. The aim of this study was to characterize collaterals in North American adult patients with Moyamoya disease and to assess whether similar correlations are valid. MATERIALS AND METHODS: Patients with Moyamoya disease (n = 39; mean age, 43.5 ±10.6 years) and age- and sex-matched control subjects (n = 33; mean age, 44.3 ± 12.0 years) were graded via angiography. Clinical symptoms of stroke or hemorrhage were graded separately by imaging. Correlations between collateralization and disease severity, measured by the modified Suzuki score, were evaluated in patients with Moyamoya disease by fitting a regression model with clustered ordinal multinomial responses. RESULTS: The presence of leptomeningeal collaterals (P = .008), dilation of the anterior choroidal artery (P = .01), and the posterior communicating artery/ICA ratio (P = .004) all correlated significantly with disease severity. The presence of infarct or hemorrhage and posterior steno-occlusive disease did not correlate significantly with the modified Suzuki score (P = .1). Anterior choroidal artery changes were not specific for hemorrhage. Patients with Moyamoya disease were statistically more likely than controls to have higher posterior communicating artery/ICA ratios and a greater incidence of leptomeningeal collaterals. CONCLUSIONS: As with Moyamoya disease in Asian patients, the presence of cerebrovascular collaterals correlated with the modified Suzuki score for disease severity in North American patients with Moyamoya disease. However, anterior choroidal artery changes, which correlated with increased rates of hemorrhage in Asian studies, were not specific to hemorrhage in North Americans.
BACKGROUND AND PURPOSE: Cerebrovascular collaterals have been increasingly recognized as predictive of clinical outcomes in Moyamoya disease in Asia. The aim of this study was to characterize collaterals in North American adult patients with Moyamoya disease and to assess whether similar correlations are valid. MATERIALS AND METHODS:Patients with Moyamoya disease (n = 39; mean age, 43.5 ±10.6 years) and age- and sex-matched control subjects (n = 33; mean age, 44.3 ± 12.0 years) were graded via angiography. Clinical symptoms of stroke or hemorrhage were graded separately by imaging. Correlations between collateralization and disease severity, measured by the modified Suzuki score, were evaluated in patients with Moyamoya disease by fitting a regression model with clustered ordinal multinomial responses. RESULTS: The presence of leptomeningeal collaterals (P = .008), dilation of the anterior choroidal artery (P = .01), and the posterior communicating artery/ICA ratio (P = .004) all correlated significantly with disease severity. The presence of infarct or hemorrhage and posterior steno-occlusive disease did not correlate significantly with the modified Suzuki score (P = .1). Anterior choroidal artery changes were not specific for hemorrhage. Patients with Moyamoya disease were statistically more likely than controls to have higher posterior communicating artery/ICA ratios and a greater incidence of leptomeningeal collaterals. CONCLUSIONS: As with Moyamoya disease in Asian patients, the presence of cerebrovascular collaterals correlated with the modified Suzuki score for disease severity in North American patients with Moyamoya disease. However, anterior choroidal artery changes, which correlated with increased rates of hemorrhage in Asian studies, were not specific to hemorrhage in North Americans.
Authors: K Wakai; A Tamakoshi; K Ikezaki; M Fukui; T Kawamura; R Aoki; M Kojima; Y Lin; Y Ohno Journal: Clin Neurol Neurosurg Date: 1997-10 Impact factor: 1.876
Authors: Qing-Shun Zhao; Gang Wang; Hao-Jiang Xiao; Wen-Feng Feng; Guo-Zhong Zhang; Ming-Zhou Li; Yong-Hong Liao; Yun-Yu Wen; Song-Tao Qi Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2018-04-20
Authors: T Matsushige; M Kraemer; T Sato; P Berlit; M Forsting; M E Ladd; R Jabbarli; U Sure; N Khan; M Schlamann; K H Wrede Journal: AJNR Am J Neuroradiol Date: 2018-06-07 Impact factor: 3.825
Authors: B A Roach; M J Donahue; L T Davis; C C Faraco; D Arteaga; S-C Chen; T R Ladner; A O Scott; M K Strother Journal: AJNR Am J Neuroradiol Date: 2016-04-07 Impact factor: 3.825
Authors: Manus J Donahue; Eric Achten; Petrice M Cogswell; Frank-Erik De Leeuw; Colin P Derdeyn; Rick M Dijkhuizen; Audrey P Fan; Rashid Ghaznawi; Jeremy J Heit; M Arfan Ikram; Peter Jezzard; Lori C Jordan; Eric Jouvent; Linda Knutsson; Richard Leigh; David S Liebeskind; Weili Lin; Thomas W Okell; Adnan I Qureshi; Charlotte J Stagg; Matthias Jp van Osch; Peter Cm van Zijl; Jennifer M Watchmaker; Max Wintermark; Ona Wu; Greg Zaharchuk; Jinyuan Zhou; Jeroen Hendrikse Journal: J Cereb Blood Flow Metab Date: 2017-08-17 Impact factor: 6.200
Authors: Travis R Ladner; Manus J Donahue; Daniel F Arteaga; Carlos C Faraco; Brent A Roach; L Taylor Davis; Lori C Jordan; Michael T Froehler; Megan K Strother Journal: J Neurosurg Date: 2016-03-11 Impact factor: 5.115
Authors: Christiaan Hendrik Bas van Niftrik; Martina Sebök; Giovanni Muscas; Marco Piccirelli; Carlo Serra; Niklaus Krayenbühl; Athina Pangalu; Oliver Bozinov; Andreas Luft; Christoph Stippich; Luca Regli; Jorn Fierstra Journal: J Cereb Blood Flow Metab Date: 2019-02-12 Impact factor: 6.200
Authors: Jennifer M Watchmaker; Meher R Juttukonda; Larry T Davis; Allison O Scott; Carlos C Faraco; Melissa C Gindville; Lori C Jordan; Petrice M Cogswell; Angela L Jefferson; Howard S Kirshner; Manus J Donahue Journal: J Cereb Blood Flow Metab Date: 2016-12-28 Impact factor: 6.200
Authors: Petrice M Cogswell; Sarah K Lants; L Taylor Davis; Meher R Juttukonda; Matthew R Fusco; Manus J Donahue Journal: Clin Neuroradiol Date: 2019-08-06 Impact factor: 3.649